Prompt 11 — Fundraise readiness
The staged funding roadmap, the dilution map, the non-dilutive money you may be eligible for and have not applied to, the data-room checklist, and the investor CRM.
Run after 07-unit-economics.md. A raise built on unknown unit economics is a raise that stalls in diligence.
Requires: 07-money past tbd, and a cap table in 01-company.
Read AGENTS.md first, then stack/CONTEXT.md, stack/01-company/company.md,
stack/03-market/market.md, stack/04-product/product.md,
stack/07-money/money.md and stack/08-capital/capital.md.
## Step 0 — Check the ground
Two files first, and stop if either is missing:
- stack/07-money/money.md past tbd. 07-unit-economics.md fills it. A raise
built on unknown unit economics does not fail at the pitch, it fails in
diligence, six weeks later, having consumed the six weeks.
- stack/01-company/company.md holding a cap table. Without it Steps 3 and 4 have
nothing to dilute and would be arithmetic on an imagined ownership split.
Then, before anything else, answer this honestly:
- Is the actual constraint capital, or is it customers, product, or focus?
- What would change with money that cannot change without it?
- What is the current revenue, and is it growing?
At the earliest stage, money rarely solves the real problem — paying customers
do, and they also make money much easier to raise. Founders who spend six months
fundraising with no revenue frequently end with neither.
If your read is that the founder should be selling rather than raising, say so
plainly and give the reasoning. Then continue anyway, because they may have a
reason you do not have.
## Step 1 — Structural blockers
Check each and flag anything that would stop or complicate a raise:
- ENTITY. Is it the right structure? Most institutional equity investors will
not invest in a proprietorship or partnership and expect a private limited
company. If a conversion is needed, note the cost, time and tax consequences.
- CAP TABLE. Complete? Does the founder hold enough for decisions and for
future dilution to still leave them motivated? If a majority sits with family
or an early holder, that is workable but it will be asked about — is there a
clean answer?
- UNDOCUMENTED EQUITY PROMISES. Anyone promised equity without a written
agreement is an open liability that surfaces in diligence at the worst
moment. List every one from 01-company and treat closing them as a blocker.
- DEAD EQUITY. Anyone holding a stake who is no longer contributing? An
investor will ask what that percentage is doing there, and "I'm not sure" is
a bad answer.
- IP OWNERSHIP. Is everything the company relies on actually assigned to it in
writing? Agency-built code, freelance design, an intern's work.
- FOUNDERS ON THE CAP TABLE. If the company is registered in someone else's
name for visa, regulatory or family reasons, say so — investors and
incubators find it unsettling and it needs a clear explanation and a
transition plan rather than a discovery in month two.
## Step 2 — Non-dilutive first
Grants do not take equity. Build the table:
| Scheme / programme | Administered by | Amount | Eligible? | Dilutive? | Deadline | Next step |
Search for what this specific company might qualify for: government innovation
and technology schemes, sector-specific programmes, state schemes, competitions
and prizes, university and accelerator programmes, and non-equity capital such
as customer prepayments, purchase-order financing and revenue-based finance.
Two honest notes to include:
There is rarely a single clean database. The work is manual: find the relevant
ministry or agency programmes, find their list of approved implementing agencies
or incubators, then check those organisations' own pages one by one for open
calls. You can pull names and URLs; a human has to check which applications are
actually live, because central lists are usually stale.
Eligibility is often narrower than it looks. Many innovation schemes target deep
technology, science and hardware and will not fund a consumer brand, a services
business or a marketplace however good it is. Check the actual criteria against
this company and say clearly which schemes it does NOT qualify for — a rejection
at the final stage costs weeks.
## Step 3 — The staged roadmap
| Stage | Amount | Type | What it buys | Milestone unlocking the next stage | Dilution | Founder % after | Timing |
Start from today's cap table and model it forward. Include the grant stage as
non-dilutive.
Then state explicitly, because these are the two things founders most often have
wrong: capital arrives in stages tied to milestones rather than in one event,
and dilution happens at every round and compounds. Show the arithmetic so the
founder is not learning it inside a term sheet.
Where possible, note how comparable companies in this sector were funded — how
much, at what stage, over how long. It calibrates expectations better than any
advice.
## Step 4 — This round
- Amount and instrument
- Use of funds, broken down by category with amounts
- Runway it buys, in months
- The milestone it unlocks — what makes the NEXT round raisable
- Valuation expectation and the basis for it
Then prepare the two questions:
"Why haven't you grown more with the traction you already have?"
"Exactly how does this money change the trajectory?"
And the exit. Name realistic acquirers — the larger player in the category, the
international group entering the market, the strategic buyer who needs this
capability — or state honestly that this is a cash-flow business, which is
legitimate and which some investors will correctly pass on.
An investor is buying an exit. Every question they ask is a version of "how does
that happen and what stops it?"
## Step 5 — Data room
Go through the checklist in 08-capital and report what exists, what is missing,
and what to do about each.
A founder who can send a complete, organised folder within an hour of a request
looks materially more credible than one who takes a week. Assemble before it is
needed.
## Step 6 — Investor pipeline
Design the CRM: columns, statuses, and the process for building it.
- What kind of investor fits this company: sector, stage, cheque size,
geography?
- Where to find them and how to research thesis fit
- Warm introductions available and through whom
- The connection note — short, a line or two: who you are, the one-line company,
one credibility marker, one specific ask
- A daily target. Thirty minutes a day, consistently, beats a two-week sprint.
Two cautions to include:
On timing: only approach investors properly when the house is in order — entity
clean, cap table sensible, data room assembled, numbers consistent. A reviewer's
job is to find the reason to say no, and a small avoidable inconsistency is a
free one. Early exploratory conversations are fine and useful, framed honestly
as relationship-building rather than an open round.
On intermediaries: some take a success fee to "help find investment" while
having no capital themselves. Check for a verifiable portfolio, a substantive
public presence, people who will speak to you, and named investments you can
confirm independently. Absence of all four is a reason to slow down.
## Output
Update stack/08-capital/capital.md. Update front matter and the INDEX row.
Finish with:
1. Whether this company is ready to raise, honestly
2. The three things to fix first, in order
3. The non-dilutive option most worth pursuing right nowNotes
Step 0 is not rhetorical. For a large share of early companies the honest answer is that they should be selling, not raising — and that a small amount of revenue would make the eventual raise far easier and cheaper.
Step 2 is where the free money is. Non-dilutive capital is strictly better than the same amount of equity, and winning a grant is itself a credibility signal. It is also where the eligibility trap lives: many innovation schemes will not fund a consumer or services business, and finding that out at the final stage costs weeks.
Step 1's undocumented-equity check is the one that blocks deals. Close those before you start, not during diligence. worksheets/advisor-scope.md.
Generated from prompts/11-fundraise-readiness.md in the repository. Edit the markdown, not this page.